Discordant Hormonal Status of Breast Cancer.

The purpose of this study is to determine discordant hormonal status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Malignant Neoplasm of Breast. Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

25 year–75 year

Sex eligibility

Female

Study type

Observational

Primary location

National Cancer Institute, Thailand.

Ratchathewi, Bangkok, 10400, Thailand

About this study

Hormonal status between primary breast tumor and axillary lymph node were analyzed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Breast cancer patients stage I,II and III with axillary lymph nodes metastasis.

Exclusion criteria

Breast cancer patients stage I,II and III without axillary lymph nodes metastasis.

Treatment and study plan

Primary outcomes

Association of hormonal status between primary breast tumor and axillary lymph nodes

Time frame: Up to 1 year

Association of estrogen and progesterone status between primary breast tumor and axillary lymph nodes was analyzed by using the χ2 test

Sponsors and collaborators

Lead sponsor

National Cancer Institute, Thailand

Other Gov

Registry information

Official study title

Discordant Hormonal Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.

Important dates

Study start: 2011
Primary completion: 2011
Study completion: 2012
First posted: Sep 16, 2013
Registry last updated: Sep 20, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed